Noramco™
Xin Lin is a Senior Analytical Scientist at Noramco™ with experience in characterizing virus and protein-based vaccine products. They have a Ph.D. in Biochemistry from Brown University and a B.S. in Chemistry from the University of Science and Technology of China. With a background in developing antibody-drug conjugates and protein-based probes, Xin has a strong research and analytical skillset in the pharmaceutical industry.
This person is not in any offices
Noramco™
Noramco, headquartered in Wilmington, Delaware, is a global leader in the production of controlled substances for the pharmaceutical industry, for medicines used to treat attention deficit hyperactivity disorder, pain, addiction, and for abuse-deterrent formulations. We realize our success through a keen focus on commercial and operational excellence as well as continuing strategic growth. Our global footprint includes Athens, GA, Wilmington, DE and Neuhausen, Switzerland. Specialists in controlled substance development and manufacturing, Noramco is a partner to the pharmaceutical industry: – Focusing on high-purity controlled substances – Leveraging intellectual property to devise the most efficient routes to APIs – Providing analytical data, chemical and physical properties, stability studies and regulatory assistance – Formulation friendly particle size grades and extended technical packages – Delivering DEA-compliant security and production capacity, from kilos to multi-ton supply – Supporting world-class supply security of controlled-substances, from schedule I to schedule III